Intrinsic Value of S&P & Nasdaq Contact Us

Cencora, Inc. COR NYSE

NYSE • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
$386.89
+20.9%
Analyst Price Target
$408.00
+27.5%

Cencora, Inc. (COR) reported total assets of $78.36B and total liabilities of $76.27B for quarter ending 2025-12-31, resulting in total equity of $2.1B.

The company held $1.81B in cash and short-term investments. Total debt stood at $7.92B, with net debt of $6.11B. The Debt-to-Equity (D/E) ratio was 3.78 (leveraged).

Current ratio is 0.92, which may signal tight short-term liquidity. Interest coverage is 10.9x (strong).

Criteria supported by this page:

  • HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (49/100) — Total assets $78.36B and equity $2.1B support the company's competitive scale
  • VALUE (32/100) — Debt-to-Equity 3.78 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 53/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
53/100
SG Score
View full scorecard →
VALUE
32/100
Price-to-Earnings & upside
→ Valuation
FUTURE
79/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
49/100
Proven by this page
~
GROWTH
48/100
→ Income
INCOME
30/100
→ Income
Cencora, Inc. Balance Sheet History
Metric Q1 FY2026 Q4 FY2025 Q3 FY2025 Q2 FY2025
Total Assets $78.36B$76.59B$73.96B$71.19B
Total Liabilities $76.27B$74.84B$71.75B$70.01B
Total Debt $7.92B$10.75B$8.24B$7.86B
Cash & Investments $1.81B$4.39B$2.28B$1.98B
Total Stockholders Equity $1.91B$1.51B$1.98B$1.01B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message